Generare raises €20M to decode the 97% of microbial chemistry Generare raises €20M to scale its microbial genome-scanning platform, which characterises novel small molecules that drug discovery AI models have never trained on.

Generare raises €20M to decode the 97% of microbial chemistry #Technology #Business #Other #FundingNews #MicrobialChemistry #BiotechInnovation

https://thenextweb.com/news/generare-20m-series-a

A promising breakthrough to enhance the effectiveness of CAR-T therapies
🙂 Another encouraging news from Groupe UIG 🚀
Read: www.drugdiscoverynews.com/new-car-t-ma...
#OncologyInnovation #Immunotherapy #BiotechInnovation #CellTherapy #CancerResearch #NextGenMedicine #PrecisionOncology

Just 3 days until the Element Biosciences User Group Meeting at ABRF in Pittsburgh!

Join us for new updates, a look at what’s ahead in 2026, and real-world insights from peers driving success in core labs.

Save your spot: https://bit.ly/4bFqsKB

#ABRF #BiotechInnovation

The need for causal data is clear: ​​the brain is one of the most complex systems​, unlocking this biology requires massively multiplexed gene perturbation directly within its native context.

This is the future of scalable drug discovery.
#SystemsBiology #CRISPR #AI #BiotechInnovation

Thank you #ADPD2026 for another excellent meeting. The $CGTX team returned with a renewed excitement about the state of the science and clinical development in neurodegenerative diseases.

#Neurology #ClinicalResearch #BiotechInnovation #DLBpsychosis

A Billionaire-Backed Startup Wants to Grow 'Organ Sacks' to Replace Animal Testing R3 Bio has a bold idea for replacing lab animals: genetically-engineered whole organ systems that lack a brain. The long-term goal, says a cofounder, is to make human versions.

A Billionaire-Backed Startup Wants to Grow 'Organ Sacks' to Replace Animal Testing #Science #Biology #MolecularBiology #OrganSacks #AnimalTesting #BiotechInnovation

www.wired.com/story/a-billionaire-back...

New Gene Therapy Trial Moves Forward Thanks to Chan Zuckerberg Initiative Backing from CZI’s Rare As One program led to a first in the push to treat FOXG1.

Backing from CZI’s Rare As One and CZI Ventures led to a first in the push to treat FOXG1.

Wendy Paris(@wendyparis.bsky.social) Reports: tinyurl.com/w33yj4rr

#RareDisease #GeneTherapy #MedicalResearch #BiotechInnovation #Philanthropy #ChanZuckerbergInitiative #HealthEquity #PatientAdvocacy

Biocontrol Seminars - Biocontrol26 We are thrilled to announce our first in-person conference, organised in collaboration with the EEBio Programme Grant. Biological Control Systems 2026 will bring together researchers, students, and in...

🚀 BioControl26 comes to Oxford on 14–15 Sept 2026!

Explore advances in biological control systems + synthetic biology.

ECR abstracts welcome. Travel support available.

👉 www.biocontrolseminars.org/biocontrol26

#SyntheticBiology #EngineeringBiology #EarlyCareerResearchers #BiotechInnovation

We'll cover general "how to", the EIC's collaborative portfolio approach&detail the sub-topics of the funding call (therapeutic approaches, biomarkers on non-animal models)

If you know someone for whom this may be if interest-spread the word!

#sciencefunding #biotechinnovation #ageingresearch

New US patent protects IV and injectable versions of nicotinamide riboside, strengthening company’s position in growing NAD+ market.

vist.ly/4ufrn

#longevity #NAD #NicotinamideRiboside #HealthyAging #Supplements #BiotechInnovation

From injection to ingestion: Can yeast make vaccines more accessible?https://ow.ly/na8W50YrS8e
#VaccineResearch #YeastBiotech #VaccineAccessibility #BiotechInnovation #VaccineDevelopment

Missed our recent updates? We pulled everything together in our 2026 innovation roadmap. 👀

From the new high-throughput VITARI™ platform to the continued evolution of AVITI24™ for spatial sequencing in tissue. 🧬🔬

🚀 See what’s next: https://bit.ly/3P5aTTh

#BiotechInnovation #AVITI24

CEO Dr. Craig Shimasaki talks about the costs of development for life sciences companies and outlines Moleculera Biosciences’ own capital needs.
youtube.com/shorts/Wxrc0...
#TranslationalMedicine #BiotechInnovation #PANDAS #Biomarkers #Biotech #LifeSciences

AI-driven supercomputing comes to pharma, promising shorter drug timelines and new opportunities in longevity research.

vist.ly/4tm59

#longevity #DrugDiscovery #AIinPharma #Supercomputing #BiotechInnovation #HealthTech #FutureOfMedicine

Company’s new benchtop system promises a clearer view of proteins following validation at a leading aging research institute.

vist.ly/4t6a3

#longevity #proteomics #biotechinnovation #agingresearch #drugdiscovery #precisionmedicine #lifescience

A second milestone for Scribe and Lilly highlights growing confidence in CRISPR as a tool for longer, healthier lives.

vist.ly/4svez

#longevity #GeneEditing #CRISPR #InVivo #BiotechInnovation #GenomicMedicine #HealthyAging #Lilly #ScribeTherapeutics

Syndex pairs a fresh diagnostic approach with $15.5m in seed funding and a clearer view of how disease and aging begin.

vist.ly/4svc9

#longevity #EarlyDetection #Diagnostics #mcPCR #PrecisionMedicine #AgingResearch #SeedFunding #BiotechInnovation

Scrappy San Diego startup goes toe-to-toe with gene-sequencing giant Illumina Element Biosciences created a high-throughput benchtop device that can deliver a whole genome for $100 – half the price of Illumina’s technology.

Thank you to Noelle Harff of The San Diego Union Tribune for covering the launch of VITARI™, the first ever high-throughput sequencing system that can deliver a $100 high-quality whole genome on the benchtop at scale.

Read the full article: https://bit.ly/4aSZMEr

#BiotechInnovation #Multiomics

We visited Biolabs Pegasus Park to speak with Dr. Craig Shimasaki, CEO of Moleculera Biosciences. He discusses the use of different disease models to identify targets to improve drug development success.
#BiotechInnovation #Biomarkers #Biotech #LifeSciences
youtube.com/shorts/tUcNw...

Insilico CEO Alex Zhavoronkov explains how machines are accelerating drug discovery and shaping longevity science.

vist.ly/4skd9

#longevity #ArtificialIntelligence #DrugDiscovery #InsilicoMedicine #BiotechInnovation #AgingResearch #PrecisionMedicine #FutureOfHealth

From a rare 14-month survival gain to a 65% lower risk of death, new long-term data puts NeuroSense’s ALS program firmly on investors’ radar.

vist.ly/4sbut

#longevity #ALS #neurology #clinicaltrials #drugdevelopment #biotechinnovation #raredisease #brainhealth

Gene therapy transforms medicine by correcting defective genes, offering hope for genetic disorders, cancer treatment, and future precision healthcare breakthroughs.
#GeneTherapy #Biotechnology #GeneticEngineering #PrecisionMedicine #MolecularBiology #BiotechInnovation #MedicalScience #LifeSciences

🎉 Beyond 2026 is now live—featuring the debut of our new high-throughput sequencing platform and expanded spatial sequencing in tissue on AVITI24™.

🚀 See it now: https://ringcentr.al/49i4HPO

#BiotechInnovation #AVITI24 #AVITI

⏳ One hour to go! Beyond 2026 starts soon and we can’t wait to unveil our new high-throughput sequencing platform. Hear the vision from the minds behind the design and learn more about our product roadmap. https://ringcentr.al/49i4HPO

#BiotechInnovation #AVITI24 #AVITI

Sana’s early diabetes data suggest hypoimmune grafts can work without systemic immunosuppression, a step toward scalable cell therapy.

vist.ly/4rwqe

#longevity #CellTherapy #GeneEditing #DiabetesResearch #Immunotherapy #RegenerativeMedicine #BiotechInnovation

Committee hears wide-ranging debate over bill to create stem-cell "regulatory sandbox" Supporters said HB 12-92 would let physicians use certain regenerative stem-cell therapies earlier than current FDA timelines and attract biotech investment; opponents and some lawmakers warned about patient protections, definitional vagueness and the risk of unproven treatments for vulnerable patients.

New Hampshire's HB 12-92 could revolutionize access to regenerative stem-cell therapies, but will it safeguard vulnerable patients from unproven treatments?

Read the full story

#NH #RegulatoryOversight #CitizenPortal #BiotechInnovation #PatientProtection #NewHampshireRegenerativeTherapies

#BlueEconomy #MarineBiotechnology #MarineBiodiversity #BlueBiotech #BiotechInnovation #BioDiscovery #AgriTech #Bioinoculants #GreenInnovation #FishFarming #Microbiome #Microbiology #BioactiveCompounds #NaturalProducts #Sustainability #DrugDiscovery #FoodProduction #Bioprotectants #AMR

FDA team describes lectin microarray for rapid glycan‑epitope profiling of intact antibodies Dr. Bao Lin Zhang outlined a first‑ and second‑generation lectin microarray that the FDA team developed to profile glycan epitopes on intact antibodies, reporting high specificity in engineered anti‑HER2 tests and comparable epitope profiles across adalimumab biosimilars.

Dr. Bao Lin Zhang unveiled a groundbreaking lectin microarray that promises rapid and precise glycan-epitope profiling of therapeutic antibodies, a game-changer for biosimilar comparability!

Click to read more!

#US #CitizenPortal #BiotechInnovation #TherapeuticAntibodies #FDALectins

Generative Ai In Life Sciences Market Growth Report 2035 Generative AI in Life Sciences Market Is Projected To Grow a Valuation of USD 98.66 Billion by 2035. Growing at a CAGR of 29.62% During the Forecast Period 2025 - 2035.

Generative Ai In Life Sciences Market Growth Report 2035 www.marketresearchfuture.com/reports/gene...
#GenerativeAI #LifeSciences #BiotechInnovation #AIResearch #HealthcareAI

Dutch biotech and leading neuroscience lab team up to explore a new way of protecting brain cells by fixing the cell’s waste system.

vist.ly/4qhyb

#longevity #Neuroscience #ParkinsonsResearch #BiotechInnovation #BrainHealth